Advertisement
UK markets closed

  • FTSE 100

    8,139.83
    +60.97 (+0.75%)
     

  • FTSE 250

    19,824.16
    +222.18 (+1.13%)
     

  • AIM

    755.28
    +2.16 (+0.29%)
     

  • GBP/EUR

    1.1675
    +0.0019 (+0.16%)
     

  • GBP/USD

    1.2487
    -0.0024 (-0.19%)
     

  • Bitcoin GBP

    51,032.84
    -559.21 (-1.08%)
     

  • CMC Crypto 200

    1,324.67
    -71.87 (-5.15%)
     

  • S&P 500

    5,110.74
    +62.32 (+1.23%)
     

  • DOW

    38,301.32
    +215.52 (+0.57%)
     

  • CRUDE OIL

    83.89
    +0.32 (+0.38%)
     

  • GOLD FUTURES

    2,346.60
    +4.10 (+0.18%)
     

  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     

  • HANG SENG

    17,651.15
    +366.61 (+2.12%)
     

  • DAX

    18,161.01
    +243.73 (+1.36%)
     

  • CAC 40

    8,088.24
    +71.59 (+0.89%)
     
PROPERTY:

9 luxury homes to consider if money is no object

Ever thought about what a multimillion pound budget would buy you?

Global Live Vaccines Market Forecast 2020-2030

ReportLinker
·2-min read

Bacterial, Viral, Oral Polio Vaccine, Measles, Rotavirus, Tuberculosis, Yellow Fever, Oral, Injectable, End Users, Hospitals, Specialty Clinics, Others. The global live vaccines market was valued at $10,423.

New York, April 13, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Live Vaccines Market Forecast 2020-2030" - https://www.reportlinker.com/p06058515/?utm_source=GNW
4 mn in 2019 and is anticipated to surpass $ 20,020 mn by 2030. In 2019, the North American segment held 39% of the global live vaccines market.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 213-page report you will receive 138 tables and 65 figures– all unavailable elsewhere.

The 213-page report provides clear detailed insight into the live vaccines market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

• Global Live Vaccines Market from 2020-2030

• Forecast of the Global Live Vaccines Market by Type of Product:
• Bacterial
• Viral

• Forecast of the Global Live Vaccines Market by Indication:
• Oral Polio Vaccine (OPV)
• Measles
• Rotavirus
• Tuberculosis
• Yellow Fever
• Others

• This report provides individual revenue forecasts to 2030 for these national markets:
• The US
• Canada
• Germany
• France
• UK
• Italy
• Spain
• Japan
• China
• India
• Brazil
• Mexico

• Our study discusses the selected leading companies that are the major players in the live vaccines market:
• AstraZeneca
• Bavarian Nordic A/S
• DAIICHI SANKYO COMPANY, LIMITED
• Emergent BioSolutions Inc.
• GlaxoSmithKline plc
• Inovio Pharmaceuticals, Inc.
• & Other Companies

• This report discusses factors that drive and restrain this market. As well as opportunities and challenges faced by this market.

• This report discusses the SWOT & PEST Analyses of the live vaccines market.

This study is intended for anyone requiring commercial analyses for the live vaccines market. You find data, trends and predictions.
Read the full report: https://www.reportlinker.com/p06058515/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001